The role of serum Cystatin C as early marker of acute kidney injury in subjects undergoing percutaneous transluminal coronary angiogram with normal serum creatinine levels
Journal Title: International Journal of Clinical Biochemistry and Research - Year 2017, Vol 4, Issue 2
Abstract
Background: Despite more than half a century of investigations, Acute kidney injury (AKI) remains a major healthcare issue in medicine today, reported to occur in 1–32% of all hospital admissions and 10–90% of intensive care unit admissions and the diagnosis of AKI is usually based on changes in Serum Creatinine (SCr) which is a poor marker of early renal dysfunction. Objectives: To study the role of Serum Cystatin C (CysC) as early marker of AKI and to correlate the Serum Cys C with conventional marker like SCr in early detection of Contrast induced acute kidney injury (CIAKI) in subjects undergoing Percutaneous transluminal coronary angiogram (PTCA). Materials and Method: Prospective cohort study was conducted, where SCr and Serum CysC were serially measured in a heterogeneous group of subjects (n=60) presenting to cardiology department and the primary outcome was CIAKI. Results: The study population consisted of 60 subjects. All subjects were divided into 2 groups: “CIAKI group” and “no-CIAKI group” according to predefined definition. The Serum Cys C increased at 4 hours and reached the peak at 24 hours, whereas SCr increased at 24 hours and reached peak at 48 hours respectively(P<0.001) and there was no significant correlation between Serum Cys C with SCr at 0 hours, 4 hours , 24 hours and 48 hours . Conclusion: Serum CysC is an early marker for detecting CIAKI compare to conventional marker SCr. So earlier detection of CIAKI by this novel biomarker can reduce morbidity and mortality and also hospital stay.
Authors and Affiliations
Shylaja T. V. , Asmabi Makandar, Raghavendra D. S. , Patnaik A. N. , Shanthi Naidu
Keywords
Related Articles
- EP ID EP296845
- DOI 10.18231/2394-6377.2017.0037
- Views 70
- Downloads 0
Liver enzymes and glycemic control markers in uncontrolled type 2 diabetes mellitus- A case control study
Introduction: Mild increase in liver enzymes, may be a marker for significant liver injury. The increased transaminases and hepatomegaly are found to be reversible with glycemic control. Objectives: 1. To compare the liv...
Prognostic significance of Ischemia Modified Albumin and role of high sensitive Creactive protein levels in acute ischemic stroke patients
Introduction: Acute ischemic stroke (AIS) is one of the leading cause of death worldwide and the main causes of long-term disability. Brain CT shows no abnormality in the early event of AIS and the infarct may not be see...
A study of serum magnesium and dyslipidemia in type 2 diabetes mellitus patients
Background: Type 2 diabetes is a heterogeneous metabolic disease characterised by insulin resistance in peripheral tissue together with impaired insulin secretion. It affects more than 285 million peoples worldwide and e...
Serum paraoxonase – Marker of alcoholic liver cirrhosis
Serum Paraoxonase is an esterase along with Apolipoprotein A1 and Clusterin Apolipoprotein J PON 1 is associated with HDL This study was done to assess the significance of serum Paraoxonase as an biomarker along with sta...
Study of free radicals (malondialdehyde) in pre-eclampsia and eclampsia in correlation with uric acid and total proteins
Introduction Oxidative stress is a normal phenomenon in normotensive pregnancy however in preeclampsia oxidative stress is exaggerated may result in a greater potential for endothelial oxidative damage It has been report...